메뉴 건너뛰기




Volumn 9, Issue 3, 2013, Pages 332-337

Standardization of analysis sets for reporting results from ADNI MRI data

(20)  Wyman, Bradley T a   Harvey, Danielle J b   Crawford, Karen c   Bernstein, Matt A d   Carmichael, Owen e   Cole, Patricia E f   Crane, Paul K g   Decarli, Charles e   Fox, Nick C h   Gunter, Jeffrey L d   Hill, Derek i   Killiany, Ronald J j   Pachai, Chahin k   Schwarz, Adam J l   Schuff, Norbert m   Senjem, Matthew L d   Suhy, Joyce n   Thompson, Paul M c   Weiner, Michael o   Jack Jr , Clifford R d  


Author keywords

ADNI; Alzheimer's disease; Analysis standards; Biomarkers; Magnetic resonance imaging

Indexed keywords

ALZHEIMER DISEASE; DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE; FOOD AND DRUG ADMINISTRATION; IMAGE QUALITY; MILD COGNITIVE IMPAIRMENT; MOTIVATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SPIN LABELING; VOLUMETRY;

EID: 84876951047     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2012.06.004     Document Type: Note
Times cited : (198)

References (10)
  • 1
    • 33144484244 scopus 로고    scopus 로고
    • Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's Disease Neuroimaging Initiative (ADNI)
    • S.G. Mueller, M.W. Weiner, L.J. Thal, R.C. Petersen, C.R. Jack, and W. Jagust Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI) Alzheimers Dement 1 2005 55 66
    • (2005) Alzheimers Dement , vol.1 , pp. 55-66
    • Mueller, S.G.1    Weiner, M.W.2    Thal, L.J.3    Petersen, R.C.4    Jack, C.R.5    Jagust, W.6
  • 6
    • 84876921017 scopus 로고    scopus 로고
    • U.S. Department of Health and Human Services. Guidance for Industry Standards for Clinical Trial Imaging Endpoints Rockville MD: U.S. Department of Health and Human Services Accessed: August 2012
    • U.S. Department of Health and Human Services. Guidance for Industry Standards for Clinical Trial Imaging Endpoints. Draft Guidance. Rockville MD: U.S. Department of Health and Human Services; 2011. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM268555.pdf. Accessed: August 2012.
    • (2011) Draft Guidance
  • 7
    • 38749114308 scopus 로고    scopus 로고
    • Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils
    • R.G. Boyes, J.L. Gunter, C. Frost, A.L. Janke, T. Yeatman, and D.L. Hill Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils Neuroimage 39 2008 1752 1762
    • (2008) Neuroimage , vol.39 , pp. 1752-1762
    • Boyes, R.G.1    Gunter, J.L.2    Frost, C.3    Janke, A.L.4    Yeatman, T.5    Hill, D.L.6
  • 9
    • 77955474927 scopus 로고    scopus 로고
    • The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes
    • L.A. Beckett, D.J. Harvey, A. Gamst, M. Donohue, J. Kornak, and H. Zhang The Alzheimer's Disease Neuroimaging Initiative: annual change in biomarkers and clinical outcomes Alzheimers Dement 6 2010 257 264
    • (2010) Alzheimers Dement , vol.6 , pp. 257-264
    • Beckett, L.A.1    Harvey, D.J.2    Gamst, A.3    Donohue, M.4    Kornak, J.5    Zhang, H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.